Safety and efficacy of S-IROX (S-1, irinotecan and oxaliplatin combination therapy) in patients with advanced pancreatic cancer: A multicenter phase 1b dose-escalation and dose-expansion clinical trial-Reference-Cited by-同舟云学术

Safety and efficacy of S-IROX (S-1, irinotecan and oxaliplatin combination therapy) in patients with advanced pancreatic cancer: A multicenter phase 1b dose-escalation and dose-expansion clinical trial

Published:2022-10 Issue: Volume:174 Page:40-47
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ohba Akihiro^ORCID,Ueno Hideki,Shiba Satoshi^ORCID,Okano Naohiro^ORCID,Kobayashi Takaaki,Nagashima Fumio,Sasahira Naoki^ORCID,Sasaki Mitsuhito,Imaoka Hiroshi,Sakamoto Yasunari^ORCID,Kondo Shunsuke,Morizane Chigusa,Ozaka Masato,Ikeda Masafumi,Furuse Junji,Okusaka Takuji

Funder

Daiichi-Sankyo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Cancer statistics, 2020;Siegel;Ca Cancer J Clin,2020

2. Pancreatic cancer;Vincent;Lancet,2011

3. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial;Hoff;J Clin Oncol,2011

4. Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer;Ueno;Cancer Chemother Pharmacol,2016

5. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study;European Journal of Cancer;2024-09

2. A phase-I study of second-line S-IROX for unresectable pancreatic cancer after gemcitabine plus nab-paclitaxel failure;Medical Oncology;2024-07-05

3. Advances in monotherapy and combination therapy of S-1 for patients with advanced non-small cell lung cancer: a narrative review;Translational Cancer Research;2024-04

4. Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial;Oncology Letters;2024-02-19

5. Effects of Probiotics on Chemotherapy-induced Diarrhea;Nutrition and Cancer;2023-10-31